Compare VANI & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VANI | PFX |
|---|---|---|
| Founded | 1998 | 2010 |
| Country | United States | United States |
| Employees | N/A | 6 |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.2M | 83.5M |
| IPO Year | 2014 | N/A |
| Metric | VANI | PFX |
|---|---|---|
| Price | $1.52 | $41.66 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 163.0K | 966.0 |
| Earning Date | 11-13-2025 | 12-16-2025 |
| Dividend Yield | N/A | ★ 3.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.06 |
| Revenue | N/A | ★ $23,958,590.00 |
| Revenue This Year | N/A | $10.24 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.06 |
| Revenue Growth | N/A | ★ 7.47 |
| 52 Week Low | $0.91 | $41.00 |
| 52 Week High | $1.92 | $57.40 |
| Indicator | VANI | PFX |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 37.98 |
| Support Level | $1.25 | $41.62 |
| Resistance Level | $1.40 | $43.50 |
| Average True Range (ATR) | 0.07 | 0.58 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 80.00 | 26.40 |
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.